HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bin Xu Selected Research

Adenocarcinoma

1/2023Elderly Pancreatic Adenocarcinoma Cancer Patients Could Benefit From Postoperative Chemotherapy.
1/2023A comparative study of gastric adenocarcinoma HER2 IHC phenotype and mass spectrometry-based quantification.
1/2022Case report: Two PD-L1 positive unresectable advanced pancreatic carcinoma patients with microsatellite stability achieved R0 resection after PD-1 antibody plus chemotherapy as a successful downstaging therapy: A report of two cases.
1/2021Cribriform architecture prostatic adenocarcinoma in needle biopsies is a strong independent predictor for lymph node metastases in radical prostatectomy.
1/2018Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma.
10/2014Biopsy characteristics in men with a preoperative diagnosis of prostatic adenocarcinoma with high Gleason score (8-10) predict pathologic outcome in radical prostatectomy.
3/2014The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature.
8/2013Lipocalin-2 is associated with a good prognosis and reversing epithelial-to-mesenchymal transition in pancreatic cancer.
3/2013Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer.
11/2012Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bin Xu Research Topics

Disease

350Neoplasms (Cancer)
05/2024 - 11/2002
76Prostatic Neoplasms (Prostate Cancer)
04/2024 - 06/2009
74Neoplasm Metastasis (Metastasis)
01/2024 - 11/2002
62Infections
01/2024 - 06/2003
46Carcinoma (Carcinomatosis)
05/2024 - 01/2003
43Inflammation (Inflammations)
01/2024 - 01/2013
41Hepatocellular Carcinoma (Hepatoma)
03/2024 - 11/2002
38Breast Neoplasms (Breast Cancer)
12/2024 - 10/2006
35Obesity
04/2024 - 05/2005
29Carcinogenesis
01/2023 - 01/2011
27Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 01/2014
26Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 01/2010
24Thyroid Neoplasms (Thyroid Cancer)
11/2023 - 12/2015
23Body Weight (Weight, Body)
04/2024 - 01/2010
23Pain (Aches)
11/2023 - 06/2008
22Wounds and Injuries (Trauma)
12/2022 - 01/2014
20Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 11/2009
19Stomach Neoplasms (Stomach Cancer)
01/2023 - 05/2006
18Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 07/2010
17Type 2 Diabetes Mellitus (MODY)
04/2024 - 11/2009
17Lung Neoplasms (Lung Cancer)
06/2023 - 11/2012
17Urinary Bladder Neoplasms (Bladder Cancer)
01/2023 - 01/2011
16Disease Progression
05/2024 - 06/2008
15Fibrosis (Cirrhosis)
05/2023 - 04/2002
15COVID-19
01/2023 - 01/2020
14Mitochondrial Diseases (Mitochondrial Disease)
03/2023 - 01/2014
14Melanoma (Melanoma, Malignant)
01/2023 - 04/2011
14Glioma (Gliomas)
01/2023 - 10/2014
14Hemorrhage
09/2022 - 03/2003
13Insulin Resistance
01/2024 - 07/2009
12Adenocarcinoma of Lung
11/2023 - 11/2011
11Stroke (Strokes)
03/2024 - 11/2015
11Hypoxia (Hypoxemia)
03/2024 - 10/2008
11Neurodegenerative Diseases (Neurodegenerative Disease)
03/2024 - 01/2017
11Hypertension (High Blood Pressure)
01/2023 - 01/2016
11Adenocarcinoma
01/2023 - 03/2009
10Constipation
12/2023 - 03/2014
10Diabetes Mellitus
12/2022 - 07/2004
10Ischemia
05/2021 - 10/2003
10Schizophrenia (Dementia Praecox)
12/2019 - 10/2005
9Spontaneous Abortion (Miscarriage)
01/2024 - 09/2013
9Atrial Fibrillation
12/2023 - 09/2011
9Neuroinflammatory Diseases
01/2023 - 07/2016
9Ovarian Neoplasms (Ovarian Cancer)
06/2022 - 06/2012
9Hyperlipidemias (Hyperlipidemia)
01/2021 - 01/2013

Drug/Important Bio-Agent (IBA)

121Proteins (Proteins, Gene)FDA Link
05/2024 - 11/2002
92Biomarkers (Surrogate Marker)IBA
03/2024 - 10/2009
48MicroRNAs (MicroRNA)IBA
03/2023 - 04/2010
42Messenger RNA (mRNA)IBA
11/2023 - 11/2002
36CytokinesIBA
11/2023 - 04/2002
32RNA (Ribonucleic Acid)IBA
01/2024 - 10/2005
32Therapeutic UsesIBA
01/2023 - 02/2004
29Long Noncoding RNAIBA
02/2024 - 09/2016
24AntigensIBA
08/2023 - 06/2009
21Glucose (Dextrose)FDA LinkGeneric
05/2024 - 07/2009
20Peptides (Polypeptides)IBA
05/2024 - 01/2014
17VaccinesIBA
02/2023 - 01/2006
16EnzymesIBA
01/2024 - 07/2010
16Circular RNAIBA
10/2023 - 01/2019
16Interleukin-6 (Interleukin 6)IBA
09/2023 - 04/2011
16Transcription Factors (Transcription Factor)IBA
07/2023 - 04/2011
15LipidsIBA
04/2024 - 07/2008
15CholesterolIBA
09/2022 - 06/2011
15AndrogensIBA
01/2020 - 06/2009
14Triglycerides (Triacylglycerol)IBA
05/2024 - 01/2014
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2024 - 02/2004
14DNA (Deoxyribonucleic Acid)IBA
01/2024 - 01/2006
14Phosphotransferases (Kinase)IBA
10/2023 - 03/2009
12Blood Glucose (Blood Sugar)IBA
04/2024 - 07/2009
12Immune Checkpoint InhibitorsIBA
03/2024 - 01/2018
12Small Interfering RNA (siRNA)IBA
12/2023 - 07/2014
12Indicators and Reagents (Reagents)IBA
12/2023 - 01/2015
12ManganeseIBA
08/2023 - 12/2016
12Insulin (Novolin)FDA Link
09/2022 - 06/2004
11Sirtuin 1IBA
04/2024 - 01/2012
11C-Reactive ProteinIBA
09/2023 - 01/2018
10Doxorubicin (Adriamycin)FDA LinkGeneric
12/2024 - 03/2009
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2023 - 10/2003
10ChromatinIBA
11/2023 - 10/2008
10LigandsIBA
01/2023 - 10/2005
9Cisplatin (Platino)FDA LinkGeneric
11/2023 - 01/2013
9Interleukin-10 (Interleukin 10)IBA
09/2023 - 04/2003
9AntibodiesIBA
05/2023 - 06/2011
9oxidized low density lipoproteinIBA
09/2022 - 01/2014
9Lysine (L-Lysine)FDA Link
01/2022 - 04/2011
9Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 07/2006
9InterleukinsIBA
07/2020 - 04/2003

Therapy/Procedure

141Therapeutics
04/2024 - 05/2008
48Drug Therapy (Chemotherapy)
05/2024 - 05/2006
36Immunotherapy
04/2024 - 01/2014
28Electroacupuncture
04/2024 - 05/2005
20Length of Stay
01/2024 - 12/2012
20Aftercare (After-Treatment)
09/2022 - 12/2008
18Radiotherapy
03/2023 - 01/2003
17Castration
11/2023 - 08/2012
12Nephrectomy
02/2024 - 01/2015
12Hepatectomy
05/2023 - 01/2004
11Lasers (Laser)
05/2024 - 09/2012
11Acupuncture Points (Acupuncture Point)
04/2024 - 12/2010
11Prostatectomy (Retropubic Prostatectomy)
01/2022 - 01/2010